Related Experiment Video
Updated: Jun 24, 2026
In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line
Haiou Liu1, Xiaodong Huang, Huimin Wang
1Jiangsu Province Key Laboratory of Neuroregeneration, Nantong University, Nantong, China.
Abstract:
Although there is ample evidence that dexamethasone (DEX) has an antiproliferative effect on C6 glioma cells, the molecular mechanism remains elusive. Src suppressed C kinase substrates (SSeCKS), as a member of PKC substrates, have been implicated to be a negative regulator of cell proliferation. In this study, we provided novel evidence that DEX induced the expression of SSeCKS mRNA and protein in a time- and dose-dependent manner, and translocation of SSeCKS from the cytosol to the membrane. The glucocorticoid receptor antagonist, RU486, significantly decreased DEX-induced SSeCKS expression, inhibited SSeCKS translocation and actin cytoskeleton reorganization after DEX challenge. Knock-down of SSeCKS expression by RNA interference inhibited DEX-induced actin cytoskeleton reorganization and reversed DEX-induced growth arrest. We also presented the novel observation that knock-down of SSeCKS expression elevated the expression of cyclin D1 and the phosphorylation of extracellular signal-regulated Kinase 1/2, indicating that SSeCKS is involved in the regulation of cell cycle related proteins and is essential for DEX induced growth arrest.
Insights
Dexamethasone (DEX) halts C6 glioma cell growth by increasing SSeCKS protein, which moves to the cell membrane. This protein is crucial for DEX's antiproliferative effects.
Area of Science:
- Molecular Biology
- Cell Biology
- Neuro-oncology
Background:
- Dexamethasone (DEX) exhibits antiproliferative effects on C6 glioma cells.
- The precise molecular mechanisms underlying DEX's action remain largely unknown.
- Src suppressed C kinase substrates (SSeCKS) are implicated as negative regulators of cell proliferation.
Purpose of the Study:
- To elucidate the molecular mechanism of DEX's antiproliferative effect on C6 glioma cells.
- To investigate the role of SSeCKS in DEX-induced growth arrest.
- To determine the relationship between SSeCKS, actin cytoskeleton, and cell cycle regulation.
Main Methods:
- Quantitative analysis of SSeCKS mRNA and protein expression.
- Cellular localization studies of SSeCKS using microscopy.
- Pharmacological inhibition using RU486 (glucocorticoid receptor antagonist).
- RNA interference (RNAi) for SSeCKS knock-down.
- Western blotting to assess protein levels and phosphorylation (e.g., ERK1/2) and cell cycle markers (e.g., cyclin D1).
Main Results:
- DEX significantly increased SSeCKS mRNA and protein expression in a time- and dose-dependent manner.
- DEX induced the translocation of SSeCKS from the cytosol to the cell membrane.
- RU486 blocked DEX-induced SSeCKS expression, translocation, and actin cytoskeleton changes.
- SSeCKS knock-down inhibited DEX-induced actin cytoskeleton reorganization and reversed growth arrest.
- SSeCKS knock-down led to increased cyclin D1 expression and ERK1/2 phosphorylation.
Conclusions:
- SSeCKS is a key mediator of DEX's antiproliferative effects on C6 glioma cells.
- DEX-induced SSeCKS expression and translocation are critical for growth arrest.
- SSeCKS plays a role in regulating cell cycle proteins and actin cytoskeleton organization in response to DEX.
